Balloon pulmonary angioplasty (BPA) is a novel treatment option for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are not eligible for pulmonary endarterectomy (PEA) or suffer from persistent pulmonary hypertension after PEA. The aim of this study was to evaluate the real-life efficacy and safety of BPA in a consecutive group of patients who were diagnosed and treated in the national referral center for CTEPH in the Czech Republic. Here we report data from 160 BPA procedures performed in 64 patients. Efficacy analysis was performed in the subgroup of 25 patients who completed BPA series. Significant improvements were observed in New York Heart Association functional class (4% to 79% in I/II, p < 0.001), 6 min walking test distance (+54.3 m, p < 0.001), risk profile (15.8% to 68.5% with presence of 2/3 low risk criteria, p < 0.001), pulmonary artery mean pressure (-18%, p < 0.001), pulmonary vascular resistance (-32%, p < 0.001), stroke volume (+17%, p = 0.011) and quality of life (+37% in assessment of overall health status by a patient, p < 0.001). We observed 1 fatal periprocedural complication (1.6% of all 64 patients) and 19 BPA-related non-fatal complications (11.9% of all 160 interventions) that predominantly included hemoptysis (10.0% of all sessions). Overall survival at 12 months was 94.6%.

2nd Department of Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University and General University Hospital 128 08 Prague Czech Republic

2nd Department of Surgery Department of Cardiovascular Surgery 1st Faculty of Medicine Charles University and General University Hospital 128 08 Prague Czech Republic

Department of Internal Medicine 1 Cardiology University Hospital 779 00 Olomouc Czech Republic

Department of Internal Medicine and Cardiology University Hospital Brno and Faculty of Medicine Masaryk University 625 00 Brno Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University 625 00 Brno Czech Republic

Zobrazit více v PubMed

Galiè N., Humbert M., Vachiery J.L., Gibbs S., Lang I., Torbicky A., Simonneau G., Peacock A., Vonk Noordegraaf A., Beghetti M., et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur. Respir. J. 2015;46:903–975. doi: 10.1183/13993003.01032-2015. PubMed DOI

Gall H., Hoeper M.M., Richter M.J., Cacheris W., Hinzmann B., Mayer E. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur. Respir. Rev. 2017;26 doi: 10.1183/16000617.0121-2016. PubMed DOI PMC

Hsieh W.C., Jansa P., Huang W.C., Nižnanský M., Omara M., Lindner J. Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis. J. Thorac. Cardiovasc. Surg. 2018;156:1275–1287. doi: 10.1016/j.jtcvs.2018.04.110. PubMed DOI

Ghofrani H.A., D’Armini A.M., Grimminger F., Hoeper M.M., Jansa P., Kim N.H., Mayer E., Simonneau G., Wilkikns M.R., Fritsch A., et al. CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N. Engl. J. Med. 2013;369:319–329. doi: 10.1056/NEJMoa1209657. PubMed DOI

Kim N.H., Delcroix M., Jais X., Madani M.M., Matsubara H., Mayer E., Ogo T., Tapson V.F., Ghofrani H.A., Jenkins D.P. Chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2019;53 doi: 10.1183/13993003.01915-2018. PubMed DOI PMC

Kawakami T., Ogawa A., Miyaji K., Mizoguchi H., Shimokawahara H., Naito T., Oka T., Yunoki K., Munemasa M., Matsubara H. Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty. Circ. Cardiovasc. Interv. 2016;9 doi: 10.1161/CIRCINTERVENTIONS.115.003318. PubMed DOI

Feinstein J.A., Goldhaber S.Z., Lock J.E., Ferndandes S.M., Landzberg M.J. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103:10–13. doi: 10.1161/01.CIR.103.1.10. PubMed DOI

Kimura M., Kohno T., Kawakami T., Kataoka M., Inohara T., Takei M., Tsugu T., Murata M., Maekawa Y., Fukuda K. Balloon pulmonary angioplasty attenuates ongoing myocardial damage in patients with chronic thromboembolic pulmonary hypertension. Int. J. Cardiol. 2016;207:387–389. doi: 10.1016/j.ijcard.2015.11.026. PubMed DOI

Ogo T., Fukuda T., Tsuji A., Fukui S., Ueda J., Sanda Y., Morita Y., Asano R., Konagai N., Yasuda S. Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension guided by cone-beam computed tomography and electrocardiogram-gated area detector computed tomography. Eur. J. Radiol. 2017;89:270–276. doi: 10.1016/j.ejrad.2016.12.013. PubMed DOI

Ogawa A., Satoh T., Fukuda T., Sugimura K., Fukumoto Y., Emoto N., Yamada N., Yao A., Ando M., Ogino H., et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of a Multicenter Registry. Circ. Cardiovasc. Qual. Outcomes. 2017;10:e004029. doi: 10.1161/CIRCOUTCOMES.117.004029. PubMed DOI

Andreassen A.K., Ragnarsson A., Gude E., Geiran O., Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99:1415–1420. doi: 10.1136/heartjnl-2012-303549. PubMed DOI

Kurzyna M., Darocha S., Koteja A., Pietura R., Torbicki A. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Postepy Kardiol. Interwencyjnej. 2015;11:1–4. doi: 10.5114/pwki.2015.49176. PubMed DOI PMC

Olsson K.M., Wiedenroth C.B., Kamp J.C., Breithecker A., Fuge J., Krombach G.A., Haas M., Hamm C., Kramm T., Guth S. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: The initial German experience. Eur. Respir. J. 2017;49:1602409. doi: 10.1183/13993003.02409-2016. PubMed DOI

Brenot P., Jaïs X., Taniguchi Y., Garcia Alonso C., Gerardin B., Mussot S., Mercier O., Fabre D., Parent F., Jevnikar M., et al. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2019;53 doi: 10.1183/13993003.02095-2018. PubMed DOI PMC

Hoole S.P., Coghlan J.G., Cannon J.E., Taboada D., Toshner M., Sheares K., Fletcher A.J., Martinez G., Ruggiero A., Screaton N., et al. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: The UK experience. Open Heart. 2020;7:e001144. doi: 10.1136/openhrt-2019-001144. PubMed DOI PMC

Anand V., Frantz R.P., DuBrock H., Kane G.C., Krowka M., Yanagisawa R., Sandhu G.S. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience. Mayo Clin. Proc. Innov. Qual. Outcomes. 2019;3:311–318. doi: 10.1016/j.mayocpiqo.2019.06.006. PubMed DOI PMC

Lindner J., Jansa P., Kunstyr J., Mayer E., Blaha J., Palecek T., Aschermann M., Grus T., Ambroz D., Tosovský J., et al. Implementation of a new programme for the surgical treatment of CTEPH in the Czech Republic--Pulmonary endarterectomy. Thorac. Cardiovasc. Surg. 2006;54:528–531. doi: 10.1055/s-2006-924465. PubMed DOI

Boucly A., Weatherald J., Savale L., Jaïs X., Cottin V., Prevot G., Picard F., de Groote P., Jevnikar M., Bergot E., et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur. Respir. J. 2017;50 doi: 10.1183/13993003.00889-2017. PubMed DOI

EQ-5D-5L User Guide. EuroQol Research Foundation; Rotterdam, The Netherlands: 2015.

Chausheva S., Naito A., Ogawa A., Seidl V., Winter M.P., Sharma S., Sadushi-Kolici R., Campean I.A., Taghavi S., Moser B., et al. Chronic thromboembolic pulmonary hypertension in Austria and Japan. J. Thorac. Cardiovasc. Surg. 2019;158:604–614.e2. doi: 10.1016/j.jtcvs.2019.01.019. PubMed DOI

Tokunaga N., Ogawa A., Ito H., Matsubara H. Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension. J. Cardiol. 2016;68:542–547. doi: 10.1016/j.jjcc.2015.11.012. PubMed DOI

Badagliacca R., Poscia R., Pezzuto B., Papa S., Reali M., Pesce F., Manzi G., Gianfrilli D., Ciciarello F., Sciomer S., et al. Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension. J. Heart Lung Transplant. 2017 doi: 10.1016/j.healun.2017.09.026. PubMed DOI

Badagliacca R., Raina A., Ghio S., D’Alto M., Confalonieri M., Correale M., Corda M., Paciocco G., Lombardi C., Mulè M., et al. Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension. J. Heart Lung Transplant. 2018;37:365–375. doi: 10.1016/j.healun.2017.08.009. PubMed DOI

Delcroix M., Staehler G., Gall H., Grünig E., Held M., Halank M., Klose H., Vonk-Noordegraaf A., Rosenkranz S., Pepke-Zaba J., et al. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients. Eur. Respir. J. 2018;52 doi: 10.1183/13993003.00248-2018. PubMed DOI

Reis A., Santos M., Vicente M., Furtado I., Cruz C., Melo A., Carvalho L., Gonçalves F., Sa-Couto P., Almeida L. Health-Related Quality of Life in Pulmonary Hypertension and Its Clinical Correlates: A Cross-Sectional Study. BioMed. Res. Int. 2018;2018 doi: 10.1155/2018/3924517. PubMed DOI PMC

Lang I., Meyer B.C., Ogo T., Matsubara H., Kurzyna M., Ghofrani H.A., Mayer E., Brenot P. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev. 2017;26 doi: 10.1183/16000617.0119-2016. PubMed DOI PMC

Kriechbaum S.D., Wiedenroth C.B., Hesse M.L., Ajnwojner R., Keller T., Sebastian Wolter J., Haas M., Roller F.C., Breithecker A., Rieth A.J., et al. Development of renal function during staged balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Scand. J. Clin. Lab. Investig. 2019;79:268–275. doi: 10.1080/00365513.2019.1601765. PubMed DOI

Riedel M., Stanek V., Widimsky J., Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81:151–158. doi: 10.1378/chest.81.2.151. PubMed DOI

Delcroix M., Lang I., Pepke-Zaba J., Jansa P., D’Armini A.M., Snijder R., Bresser P., Torbicki A., Mellemkjaer S., Lewczuk J., et al. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. 2016;133:859–871. doi: 10.1161/CIRCULATIONAHA.115.016522. PubMed DOI

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic